| The Alliance’s initial objectives include: |
|
 |
To advocate to Congress and the U.S. Department of Health and Human Services for fair access to IVIG |
|
|
To ensure fair and adequate reimbursement for all brands of IVIG in all sites of care: physician office, independent clinic, hospital and homecare |
|
|
To update IVIG coverage and dosing guidelines for all relevant diseases |
|
|
To be an IVIG access information resource for patient organizations, provider communities, Congress, federal and state agencies and others |
|
|
To support the creation of a Congressional Taskforce on IVIG Access to work in conjunction with the Alliance on all legislative and public policy activities |
